Exicure, Inc. (XCUR)
| Previous close | 2.1600 |
| Open | 2.1000 |
| Bid | 2.0400 x 900 |
| Ask | 2.0700 x 800 |
| Day's range | 2.0400 - 2.1500 |
| 52-week range | 2.0200 - 59.4000 |
| Volume | |
| Avg. volume | 443,297 |
| Market cap | 206.301M |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.7170 |
| Earnings date | 09 Mar 2022 - 14 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.13 |
- Business Wire
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
CHICAGO, June 29, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of business tomor
- Business Wire
Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders
CHICAGO, May 27, 2022--Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the "Annual Meeting") held in virtual format on Friday, May 27, 2022 at 1:00 p.m. Central Time, was convened and adjourned until June 10, 2022 at 1:00 p.m. Central Time wit
- Business Wire
Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
CHICAGO, May 17, 2022--Exicure today announced that CEO Matthias Schroff will provide a virtual presentation at the 2022 H.C. Wainwright Global Life Sciences Conference.
